Nitric oxide (dNO) is a biologically important short-lived free radical signaling molecule. Both the enzymatic synthesis and the predominant forms of cellular metabolism of dNO are oxygen-dependent. For these reasons, changes in local oxygen concentrations can have a profound influence on steadystate dNO concentrations. Many proteins are regulated by dNO in a concentration-dependent manner, but their responses are elicited at different thresholds. Using soluble guanylyl cyclase (sGC) and p53 as model dNO-sensitive proteins, we demonstrate that their concentration-dependent responses to dNO are a function of the O 2 concentration. p53 requires relatively high steady-state dNO concentrations ( 4 600 nM) to induce its phosphorylation (P-ser-15), whereas sGC responds to low dNO concentrations ( o 100 nM). At a constant rate of dNO production (liberation from dNO-donors), decreasing the O 2 concentration (1%) lowers the rate of dNO metabolism. This raises steady-state dNO concentrations and allows p53 activation at lower doses of the dNO donor. Enzymatic dNO production, however, requires O 2 as a substrate such that decreasing the O 2 concentration below the K m for O 2 for nitric oxide synthase (NOS) will decrease the production of dNO. We demonstrate that the amount of dNO produced by RAW 264.7 macrophages is a function of the O 2 concentration. Differences in rates of dNO production and dNO metabolism result in differential sGC activation that is not linear with respect to O 2 . There is an optimal O 2 concentration (E 5-8%) where a balance between the synthesis and metabolism of dNO is established such that both the dNO concentration and sGC activation are maximal.
Introduction
Nitric oxide (nitrogen monoxide, dNO) is a short-lived signaling molecule involved in regulating numerous physiological and pathological functions. Nitric oxide is synthesized by nitric oxide synthase (NOS) of which there are three main isoforms (iNOS, eNOS, nNOS). The substrates for this enzyme are arginine and oxygen (O 2 ). Also, NADPH, FMN, BH 4 , and FAD are required as cofactors. Not surprisingly, changes in the availability of any one of these substrates or cofactors can affect the rate of dNO production. When there is an abundance of cofactors, the rate of dNO synthesis will be a function of both the arginine and O 2 concentrations. Arginine availability can vary based on cellular uptake and competing consumptive pathways (i.e. arginase and the urea cycle). The O 2 availability in tissues is a function of its rate of delivery from the vasculature and the rate at which it is consumed locally via mitochondrial respiration. The K m 's for arginine and O 2 are different for each NOS isoform, thus changes in substrate concentrations will alter the dNO output in an isoform-dependent manner. The K m 's for O 2 for eNOS, iNOS and nNOS are 23 mM, 135 mM and 350 mM respectively. These differences indicate that for a given O 2 concentration the rate of dNO synthesis from nNOS will be dramatically affected while production from eNOS will remain comparatively constant [1] . Since many phenotypic responses to dNO occur in a concentration-dependent manner [2] , the cellular response to dNO produced in a relatively hypoxic environment could be substantially different than in tissues which are well oxygenated even if they express an equivalent amount and type of NOS.
The steady-state concentration of dNO ([dNO ss ]) is determined by the balance between its rate of production and its rate of disappearance. Although several studies have attempted to elucidate the mechanism(s) of cellular dNO metabolism, to date the dominant pathway(s) for this process remains undetermined.
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We and others have shown, however, that metabolism of dNO by non-erythroid cells is an O 2 -dependant process. Kinetic studies indicated that, although dNO metabolism requires O 2 , it is not a direct reaction of dNO with O 2 (autooxidation) [3] . Herein, we demonstrate that the local O 2 concentration determines [dNO] SS which differentially regulates signaling responses to dNO. [4,3-a] quinoxalin-1-one (ODQ), lipopolysaccharides (LPS) and aminoguanidine hydrochloride were purchased from Sigma. All cell culture reagents were purchased from Invitrogen.
Materials and methods

Chemicals
(Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen- 1-ium-1,2-diolate (DETA/NO) and (Z)-1-[N-[3-aminopropyl]-N- [4-(3-aminopropylammonio)butyl]-amino]diazen-1-ium-1,2-dio
Cell culture
MCF-7 human breast carcinoma cells and RAW 264.7 murine macrophages were cultured in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. All cells were grown to 85% confluence and MCF-7 cells were serum-starved overnight prior to treatment. To achieve a hypoxic environment (o21% O 2 ), cells were grown in a hypoxic chamber glove-box (Coy Scientific) at 37 1C and 5% CO 2 . Oxygen concentration was constantly monitored and regulated by purging with nitrogen gas. RAW 264.7 cells were activated using LPS (1 mg/ml) to induce iNOS expression. For coculture experiments, activated RAW 264.7 cells were trypsinized, counted and added at indicated densities to MCF-7 cells in serum free media in the presence or absence of aminoguanidine (1 mM), an iNOS inhibitor. To inhibit sGC, MCF-7 cells were pretreated with 10 mM ODQ for 30 minutes prior to addition of RAW 264.7 cells.
Western Blotting
Whole cell lysates were collected using CellLytic TM M Cell Lysis Reagent (Sigma), supplemented with 1% protease inhibitor cocktail (Calbiochem) and 1 mM PMSF (Sigma). Proteins were transferred to polyvinylidene difluoride (PVDF) membranes using the iBlot transfer system (Invitrogen). The membranes were blocked with 5% nonfat dry milk in Tris-glycine-SDS containing 0.1% Tween 20 for 1 h at room temperature. They were then incubated overnight at 4 1C with suitable primary antibodies: p53 P-Ser-15, p53, b-actin (Cell Signaling Technology, Beverly, MA, USA) or iNOS (Santacruz Biotechnology, Santa Cruz, CA, USA). After incubation with horseradish peroxidase-conjugated secondary anti-rabbit antibody (Cell Signaling Technology, Beverly, MA, USA) for 1 h, the blots were analyzed in a Fluor Chem HD2 imager (Alpha Innotech) using SuperSignal West Femto Maximal Sensitivity Substrate (Thermo Scientific).
cGMP Measurements
MCF-7 cells were grown to 50% confluency in 96-well microtiter plates. Cells were serum-starved overnight and treated with various concentrations of Sper/NO or cocultured with activated RAW 264.7 macrophages at different densities. After the removal of dNO source, MCF-7 cells were lysed at the indicated time points, and cell extracts were assayed for cGMP by enzyme immunoassay (Amersham Biosciences).
Cellular dNO metabolism
Rates of disappearance of dNO were measured as described previously [4] . RAW 264.7 cells were trypsinized and put into a reaction chamber at 6 Â 10 6 cells/ml of serum-free media. Cell suspensions were constantly stirred in a sealed, water-jacketed, temperature-controlled (37 1C) chamber. The reaction chamber was equipped with both dNO and O 2 electrodes connected to an Apollo 4000 free radical analyzer (World Precision Instruments, Sarasota, FL, USA). Headspace in the vessel was negligible compared to the vessel volume to ensure that the rate of dNO volatilization was insignificant compared with its reaction in solution. Reactions were initiated by injection of a saturated dNO solution with a gas-tight syringe, and dNO metabolism was measured using an dNO-selective electrode (amiNO-700, response time of o0.2 s, sensitivity of 25 nM; Innovative Instruments, Tampa, FL, USA).
Real-time dNO measurements
MCF-7 cells were grown in 10 cm culture dishes and an dNO-selective electrode (amiNO-700, Innovative Instruments) connected to an Apollo 4000 free radical analyzer (World Precision Instruments) was positioned $1 mm above, and perpendicular to the cellular monolayer. After equilibration for 2 h at 37 1C, dNO donor compounds were added and steady-state dNO concentrations were measured over time.
Accumulation of dNO metabolites in the media was measured by chemiluminescence with a Sievers nitric oxide analyzer 280i.
25 ml aliquots of media were injected into a reaction chamber containing vanadium chloride in HCl as described previously [4] .
Statistics
Significance was determined using either t-test or one way ANOVA with Bonferoni post-hoc analysis. Error bars indicate SEM.
Results
Proteins respond to dNO in a concentration-dependent manner
We and others have shown that the tumor suppressor protein p53 is phosphorylated at the serine 15 residue (p53 P-Ser-15) in response to relatively high steady-state concentrations of dNO (4600 nM [dNO] SS ) [5] . Conversely, relatively low concentrations of dNO (o100 nM [dNO] SS ) activate soluble guanylyl cyclase (sGC) [6] . The differing sensitivities of these proteins to dNO makes them, in effect, biological dNO dosimeters. We treated MCF-7 cells with increasing concentrations of the dNO-donor Sper/NO and measured changes in p53 P-Ser-15 and cGMP production. When the Sper/NO concentration was increased, the [dNO] ss concentration rose in a corresponding manner (Fig. 1A) . As predicted, p53 was phosphorylated at the highest concentration of Sper/NO which produced [dNO] ss concentrations approaching 1 mM (Fig. 1B) . Next, cGMP was measured in these cells as an indicator of sGC activation (Fig. 1C) . Very low dNO concentrations were sufficient for maximal sGC activation (E5 mM Sper/NO, o50 nM [dNO] SS ).
The impact of O 2 concentration on [dNO] ss
We have previously shown that, for a given cell type and density, the rate of cellular dNO metabolism displays first-order kinetics which is a function of the both the dNO and O 2 concentrations (Eq. 1) [3] .
Using an dNO-selective electrode, we measured differences in dNO metabolism after either bolus addition or continuous exposure to dNO at 1% and 21% O 2 . For the purposes of this study, metabolism is defined as the disappearance of dNO in the presence of cells. Fig. 2A demonstrates that when cells in suspension received a 1000 nM dNO bolus, dNO metabolism was slower at 1% than at 21% O 2 (t 1/2 ¼260s vs. 45 s). We also measured [dNO] ss in the culture media of cells treated with the dNO-donor DETA/NO at either 1% or 21% O 2 . The rate of dNO liberation from diazeniumdiolates such as DETA/NO is a function of pH and temperature and it is not affected by differences in O 2 concentration [7] . For an equivalent concentration of DETA/NO (500 mM), the [dNO] ss was greater at 1% O 2 than it was at 21% O 2 ( Fig. 2B ). These observed differences in [dNO] ss at 1% vs. 21% O 2 can be partially attributed to differences in the rates of dNO metabolism which decreases as the O 2 concentration is lowered. For cell culture experiments, the volume of media far exceeds the volume of cells. Therefore, in addition to cellular metabolism, the disappearance of dNO can result from other consumptive processes such chemical reactions in the media. The predominant reaction of dNO in the media is with dissolved O 2 through the autooxidation reaction [8] . This reaction is first-order with respect to the O 2 concentration (Eq. 3) and, therefore, its rate will vary based on differences in O 2 . We calculated the contribution of this reaction to the observed differences in the rates of dNO disappearance at both O 2 concentrations. Autooxidation occurs with the following overall stoichiometry [8] :
The rate of disappearance of dNO through this reaction is given by
where k¼1.8-6.6 Â 10 6 M À 2 s À 1 . Calculations of dNO disappearance via the autooxidation reaction at 1% and 21% O 2 are shown in Fig. 2C and D. These illustrate the well-known fact that the half-life of dNO is inversely correlated to the dNO concentration and the O 2 concentration. At 1% O 2 , the half-life of dNO is on the order of hours to days at 1000 nM dNO (Fig. 2C) . At 21% O 2 , the half-life of dNO is reduced to minutes or hours (Fig. 2D ). These calculations reveal that, at 1% O 2 , 1000 nM dNO disappears E58 times slower via the autooxidation reaction than in the presence of cells ( Fig. 2A) and E15 times slower at 21% O 2 . The lower the dNO concentration, however, the less autooxidation contributes to the observed differences in the rates of dNO disappearance in the presence of cells because autooxidation is second order in dNO. This is exemplified in Fig. 2E , which demonstrates that the disappearance of 200 nM dNO is negligible in the absence of cells.
In addition to cellular consumption and autooxidation, there are other means by which dNO can disappear in cell culture experiments. These include volatilization from the culture flask and reactions with other components in the media [7] . In comparison to the reaction of dNO with cells or O 2 , the disappearance of dNO via other mechanisms should be constant at any O 2 concentration. As a result, these other consumptive pathways should not be a confounding factor when observing differences in the rates of dNO disappearance at different O 2 concentrations. Our data indicate that the dominant mechanism of dNO loss is via cellular metabolism, which prevails over other processes including autooxidation. 
Oxygen modulates dNO signaling processes
At a constant rate of dNO production (i.e. from dNO-donor compounds), the [dNO] ss is predominantly a function of the O 2 -dependant rate at which it is metabolized by cells (Fig. 2B) . We set out to determine if the effect of O 2 on [dNO] ss would differentially affect dNO-regulated signaling. To test this, we measured the accumulation of p53 Ser-15 phosphorylation in MCF-7 cells treated with increasing concentrations of the dNOdonor Sper/NO at either 1% O 2 or 21% O 2 for 2 h. Fig. 3 demonstrates that, at 1% O 2 , the concentration of Sper/NO necessary to induce p53 P-Ser-15 is only one fourth of the amount required at 21% O 2 . For a given Sper/NO concentration, the rate of dNO production is the same at both O 2 concentrations, yet the [dNO] ss is greater at 1% O 2 due to differences in the rates of cellular dNO metabolism. Since p53 phosphorylation requires a specific threshold concentration of dNO (Fig. 1B) at a constant rate of dNO production, it is the O 2 concentration that ultimately determines the extent of dNO signaling.
Oxygen determines the rate of enzymatic dNO synthesis
Unlike the liberation of dNO from synthetic donors, the biological production of dNO is enzymatic and requires molecular O 2 as a substrate. For a given NOS isoform, changes in O 2 concentrations will affect enzymatic dNO production. To demonstrate this, we cultured RAW 264.7 macrophages over a range of O 2 concentrations and stimulated them with LPS to induce iNOS expression and dNO production. The total amount of enzymatic dNO synthesis was determined by measuring the accumulation of NO 3 À /NO 2 À in the media over time. In Fig. 4A it can be seen that, as expected, there was a temporal and linear increase in dNO production as the O 2 concentration rose from 1-8%. More importantly, however, above 8% O 2 no further increase in the rate of dNO production was observed. This indicates that O 2 is no longer a limiting factor for dNO synthesis at concentrations greater than 8%.
Hypoxia is known to affect the magnitude of iNOS expression which could potentially influence the overall amount of dNO synthesis [4] . We examined this possibility by culturing RAW 264.7 cells over a range of O 2 concentrations and measuring the levels of iNOS expression subsequent to LPS stimulation. (Fig. 4C, columns 1,2,4 ,5). At both time points, the amount of dNO synthesis was considerably higher at 21% O 2 than at 1% O 2 as seen in Fig. 4A .
To understand the effects of differences in enzyme expression on dNO synthesis, we cultured RAW 264.7 cells for 16 h at 1% O 2 . This resulted in a substantial increase in cellular iNOS protein expression (Fig. 4B) . After 16 h these cells were moved to 21% O 2 for an additional 8 h (24 h total) and NO 2 À /NO 3 À was measured (Fig. 4C, column 3) . This resulted in a dramatic increase in dNO production at 21% O 2 that we attributed to the hypoxia-mediated increase in iNOS expression (Fig. 4C, compare columns 1, 2 and 3 ).
This experiment was repeated, but the order of oxygen exposure was reversed; 21% O 2 for 16 h followed by 8 h at 1% O 2 (Fig. 4C,  column 6 ). Under these conditions, total dNO synthesis was substantially diminished (Fig. 4C, compare columns 3,6 ). Together these results indicate that at 21% O 2 enzyme concentration is the major limiting factor for dNO synthesis whereas at 1% O 2 , oxygen is the major limiting factor. Therefore, the oxygen concentration can influence dNO production by changing the amount of iNOS expressed or as a limiting substrate for this enzyme.
Oxygen regulates the magnitude of dNO signaling
Having determined that changes in O 2 concentration could influence both the rate of enzymatic dNO production and dNO metabolism, we went on to examine the impact of these processes on dNO signaling. For these experiments we developed a co-culture model in which MCF-7 cells were cultured in the presence of dNO-producing RAW 264.7 cells. After isolation of the MCF-7 cells, sGC activation was measured by monitoring the cGMP production. Fig. 5A demonstrates that sGC in the target MCF-7 cells was activated in response to RAW 264.7-derived dNO. Cyclic GMP production in the MCF-7 cells was not detected when cells were treated with ODQ, co-cultured with nonactivated RAW 264.7 cells or activated RAW cells treated with the iNOS inhibitor aminoguanidine (Fig. 5A) . Next, we altered oxygen levels by culturing the cells at different O 2 concentrations (1-21%) and modulated the dNO concentration by changing the ratio of RAW 264.7/MCF-7 cells. We then repeated the co-culture experiment over a range of O 2 and dNO concentrations. Fig. 5B demonstrates that sGC activation was dependent on both the O 2 concentration and the number of dNO-producing cells. Interestingly, the optimal O 2 concentration for maximal cGMP production was at E5-8% O 2 . This suggests that at this O 2 concentration dNO production and dNO consumptive processes are optimized to maximize steady-state dNO concentration and sGC activation.
Discussion
Nitric oxide is a small, uncharged, freely diffusible gas that under biological conditions reacts with other free radicals (including oxygen) and metals. Its unique biochemical properties allow it regulate, and sometimes disrupt, numerous aspects of cell physiology. In addition to dNO's ability to activate signal transduction cascades, it can also directly inhibit respiration and sequester cellular iron. Unfortunately, the same properties that confer this diversity of function also make it extremely challenging to predict its exact [dNO] Many in vivo studies use the expression levels of NOS as justification for dNO-attributable responses [9] . It is often not appreciated that the overall amount of synthesized dNO cannot easily be inferred solely by examining the levels of NOS protein.
Our results demonstrate that both the O 2 concentration and the amount of NOS protein are equally important determinants of the amount of dNO synthesized. The relative contribution of both of these parameters varies with the O 2 concentration. At high O 2 , dNO synthesis is dependent on the amount of enzyme present, while at low O 2 , oxygen itself becomes the limiting factor.
We used a dNO-selective electrode to measure the [dNO] ss in the dNO-donor treated media of cells grown in monolayer. Since dNO is freely diffusible into cells, its steady-state concentration in the media is in equilibrium with its concentration in the cells. This allows for a precise measurement of [dNO] ss and the identification of signaling cascades that correspond to specific dNO concentrations. As we have previously reported, dNOmediated cellular signaling is stratified with numerous signaling pathways being activated by differential [dNO] ss [2] . Our current study builds on these findings by demonstrating how dNO signaling can be significantly modified by the O 2 concentration. In many ways these results are expected given the ability of O 2 to modulate dNO concentrations. However, our results demonstrate that changes in dNO signaling do not always change linearly with changing O 2 concentrations.
When the rate of dNO production is constant, its steady-state concentration is predominantly a function of its O 2 -dependant rate of metabolism. We demonstrate that, at lower O 2 concentrations, dNO metabolism is considerably slower, and thus [dNO] ss is higher. This inverse relationship has a direct effect on dNO signaling. Activation of p53 Ser-15 phosphorylation at 1% O 2 , for example, is possible with one-fourth the dose of Sper/NO necessary to achieve the same effect at 21% O 2 . This indicates that, for a given rate of dNO production (synthesis), lowering the O 2 concentration will enable activation of signaling pathways that are not obtainable at higher O 2 concentrations.
In addition to dNO consumptive pathways, we show that O 2 concentrations influence [dNO] ss by affecting its rate of enzymatic synthesis. Oxygen is a necessary substrate for NOS, and the oxygen gradient itself regulates iNOS expression [4] . Our data reveals that, in dNO-producing RAW 264.7 cells, the rate of dNO synthesis increases in a linear fashion from 1-8% O 2 . Above this amount of O 2 , further increases in the rate of dNO synthesis were not observed. When sGC activation by dNO was examined under changing O 2 concentrations, we noted maximal activation at 5-8% O 2 . At O 2 concentrations higher or lower than these amounts, there was a decrease in sGC activation. We suggest that the balance between O 2 availability and enzyme expression at 5-8% O 2 is optimized such that the rate of dNO production versus its rate of metabolism synergize to achieve maximal [dNO] ss . At higher O 2 concentrations, dNO production is maximal but so is its metabolism. At lower O 2 concentrations, dNO metabolism is slowest but so is its enzymatic synthesis.
Conclusions
These findings highlight the importance and dependence of O 2 on biological responses to dNO. The principals discussed in this study are important to consider when assigning a functional role to dNO in the context of numerous normal and disease conditions where oxygen gradients exist. The tissue microenvironment will drive [dNO] ss , thereby modifying which signal transduction cascades are triggered to ultimately influence cellular phenotype. Some of the disparities seen in dNO signaling are thus the result of O 2 mediated changes in [dNO] ss . These are important factors to consider when trying to elucidate the biochemical responses to dNO synthesis and also the effects of therapeutic dNO donors especially in the context of changing oxygen environments.
